Nu Skin Enterprises EVP Justin Keisel Begins Medical Leave

What Happened Nu Skin Enterprises, Inc. (NUS) filed an 8-K (Item 5.02) reporting that Justin Keisel, the Company’s Executive Vice President and President of Global Sales, began a medical leave of absence effective August 17, 2026. The company announced that Chayce Clark, Executive Vice President, Chief Operating Officer and Chief Legal Officer, will lead Mr. Keisel’s organization during his time away. The filing was made on August 21, 2026.

Key Details

• Effective date of leave: August 17, 2026.
• Executive on leave: Justin Keisel, EVP & President of Global Sales.
• Interim leadership: Chayce Clark (EVP, COO & Chief Legal Officer) will run Keisel’s organization.
• Filing: Form 8-K submitted August 21, 2026 under Item 5.02 (departure/election of directors or certain officers); the filing describes a medical leave, not a resignation.

Why It Matters This is a temporary change in sales leadership reported by the company. Nu Skin named an internal senior executive to run the global sales organization to maintain continuity. Investors should note the change in management responsibilities and watch for any future disclosures about Mr. Keisel’s return or further leadership updates that could affect sales execution or company operations.